Post job

Imperial CRS's revenue is $29.3 million.

What is Imperial CRS's revenue?

Imperial CRS's annual revenue is $29.3M. Zippia's data science team found the following key financial metrics about Imperial CRS after extensive research and analysis.
  • Imperial CRS has 150 employees, and the revenue per employee ratio is $195,600.
  • Imperial CRS peak revenue was $29.3M in 2024.

On this page

Peak revenue
$29.3M (2025)
Company peak revenue
Revenue / employee
$195,600
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$29.3M (2025)
Company peak revenue
Revenue / employee
$195,600
Company revenue / employee

Imperial CRS competitors

Imperial CRS's top competitor, Essilor USA, earned an annual revenue of $8.1B.

Imperial CRS's smallest competitor is Alpha Systems with revenue of $60.0K last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
ThreeWire, Inc.$54,853$14.0M161-
Continuum Clinical$32,734$44.0M103-
StudyKIK$64,871$29.0M125-
OE Enterprises$46,280$25.0M507
Alpha Systems$44,255$60,00078
rms$50,140$340.0M70033
American Society of Clinical Oncology$60,124$144.5M66315
CME$48,220$350,00062
Alltech$77,712$1.6B3,00149
Premier Inc.$59,611$1.3B2,600536

Imperial CRS revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Imperial CRS, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Imperial CRS. The employee data is based on information from people who have self-reported their past or current employments at Imperial CRS. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Imperial CRS. The data presented on this page does not represent the view of Imperial CRS and its employees or that of Zippia.

Imperial CRS may also be known as or be related to Imperial CRS and Imperial Clinical Research Services Inc.